45 results
ARS
2024 FY
ABSI
Absci Corp
23 Apr 24
Annual report to shareholders
4:10pm
bonus program is designed to recognize and reward achievement of company goals and individual performance as measured by impact and demonstration … Bonus Plan (filed as Exhibit 10.4 to the Form S-1, File No. 333-257553, filed by Absci Corporation on July 15, 2021 and incorporated herein by reference
8-K
tfnl5bmr8zqn
17 Aug 23
Departure of Directors or Certain Officers
5:02pm
8-K
mhaf41mm3n69kz
14 Aug 23
Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results
8:13am
8-K
EX-1.1
ezhmg4oaslo0sh dh1
16 Jun 23
Entry into a Material Definitive Agreement
4:23pm
ARS
e1nw56qnbv4a484i
28 Apr 23
Annual report to shareholders
12:00am
PRE 14A
ieax lup751pgzpm
11 Apr 23
Preliminary proxy
5:49pm
8-K
q6wuxw 0sxggk546
4 Oct 22
Absci Appoints Veteran Pharma Executive Andreas Busch, PhD as Chief Innovation Officer
4:09pm
DEF 14A
uazexeinlxut 045a7z
26 Apr 22
Definitive proxy
4:39pm
10-K
phlzhspam mw
22 Mar 22
Annual report
5:20pm